[1]	Wong A, Yusuf GT, Malbrain M. Future developments in the imaging of the gastrointestinal tract:the role of ultrasound[J]. Curr Opin Crit Care, 2021, 27(2):147-156.DOI:10.1097/MCC.0000000000000815. Cited in this article [1]

[2]	Liao D, Frøkjaer JB, Yang J, et al. Three-dimensional surface model analysis in the gastrointestinal tract[J]. World J Gastroenterol, 2006, 12(18):2870-2875.DOI:10.3748/wjg.v12.i18.2870. Cited in this article [1]

[3]	Wang FH, Zhang XT, Tang L, et al. The Chinese Society of Clinical Oncology (CSCO):clinical guidelines for the diagnosis and treatment of gastric cancer,2023[J]. Cancer Commun (Lond), 2024, 44(1):127-172.DOI:10.1002/cac2.12516. Cited in this article [1]

[4]	Liu Z, Ren W, Guo J, et al. Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS)[J]. Gastric Cancer, 2018, 21(5):879-888. DOI:10.1007/s10120-018-0798-x. Cited in this article [2]

[5]	Liu Z, Guo J, Wang S, et al. Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for gastric cancer[J]. BMC Cancer, 2015,15:932.DOI:10.1186/s12885-015-1943-0. Cited in this article [1]

[6]	Zhang X, Yao J, Zhang Y, et al. Updated evaluation of the diagnostic performance of double contrast-enhanced ultrasonography in the preoperative T staging of gastric cancer:a meta-analysis and systematic review[J]. Front Oncol, 2022, 12:844390.DOI:10.3389/fonc.2022.844390. Cited in this article [2]

[7]	Liu L, Lu DY, Cai JR, et al. The value of oral contrast ultrasonography in the diagnosis of gastric cancer in elderly patients[J]. World J Surg Oncol, 2018, 16(1):233.DOI:10.1186/s12957-018-1527-y. Cited in this article [1]

[8]	Zhong Y, Xiao YY, Ye JY, et al. Diagnostic efficacy of contrast-enhanced gastric ultrasonography in staging gastric cancer:a meta-analysis[J]. BMC Cancer, 2024, 24(1):422.DOI:10.1186/s12885-024-12210-z. Cited in this article [2]

[9]	Zheng XZ, Zhang LJ, Wu XP, et al. Oral contrast-enhanced gastric ultrasonography in the assessment of gastric lesions:a large-scale multicenter study[J]. J Ultrasound Med, 2017, 36(1):37-47.DOI:10.7863/ultra.16.01053. Cited in this article [2]

[10]	Shi H, Yu XH, Guo XZ, et al. Double contrast-enhanced two-dimensional and three-dimensional ultrasonography for evaluation of gastric lesions[J]. World J Gastroenterol, 2012, 18(31):4136-4144.DOI:10.3748/wjg.v18.i31.4136. Cited in this article [3]

[11]	Wang L, Liu Z, Kou H, et al. Double contrast-enhanced ultrasonography in preoperative T staging of gastric cancer:a comparison with endoscopic ultrasonography[J]. Front Oncol, 2019, 9:66.DOI:10.3389/fonc.2019.00066. Cited in this article [2]

[12]

Liu Z, Guo J, Ren W, et al. A gastric calcifying fibrous pseudotumor detected by transabdominal ultrasound after oral administration of an echoic cellulose-based gastrointestinal ultrasound contrast agent[J]. Ultraschall Med, 2014, 35(2):181-183. DOI:10.1055/s-0033-1350396. Cited in this article [1]

[13]	Guan S, Yan R, Chen X, et al. Risk stratification of gastric cancer screening in community population based on oral contrast-enhanced ultrasonography examination:a 3-year follow-up analysis report[J]. Front Oncol, 2023, 13:1218800.DOI:10.3389/fonc.2023.1218800. Cited in this article [2]

[14]	Shen L, Zhang D, Huang Y, et al. Initial screening of gastric cancer using oral contrast-enhanced trans-abdominal ultrasonography in rural asymptomatic individuals[J]. Cancer Epidemiol, 2022, 80:102236.DOI:10.1016/j.canep.2022.102236. Cited in this article [2]

[15]	Mu K, Sun Q, Li X, et al. The value of oral contrast-enhanced gastric ultrasonography in the diagnosis and staging of benign peptic ulcer[J]. Sci Rep, 2024, 14(1):17390.DOI:10.1038/s41598-024-68430-7. Cited in this article [1]

[16]	Gai Q, Li X, Li N, et al. Clinical significance of multi-slice spiral CT,MRI combined with gastric contrast-enhanced ultrasonography in the diagnosis of T staging of gastric cancer[J]. Clin Transl Oncol, 2021, 23(10):2036-2045.DOI:10.1007/s12094-021-02606-9. Cited in this article [2]

[17]	Wang X, Kou H, He H, et al. Difference in perfusion parameters between gastric cancer and gastric stromal tumors:evaluation with rral contrast plus contrast-enhanced ultrasonography[J]. Front Oncol, 2020, 10:532.DOI:10.3389/fonc.2020.00532. Cited in this article [1]

[18]	Shen HL, Yang SP, Wang KJ, et al. Evaluation of gastric blood supply in diabetic patients with gastroparesis by contrast-enhanced ultrasound[J]. Br J Radiol, 2016, 89(1068):20160366.DOI:10.1259/bjr.20160366. Cited in this article [1]

[19]	He H, Tang T, Wang X, et al. Comparing endoscopic ultrasonography and double contrast-enhanced ultrasonography in the preoperative diagnosis of gastric stromal tumor[J]. Cancer Imaging, 2023, 23(1):122.DOI:10.1186/s40644-023-00646-8. Cited in this article [1]

[20]	Piscaglia F, Nolsoe C, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS):update 2011 on non-hepatic applications[J]. Ultraschall Med, 2012, 33(1):33-59.DOI:10.1055/s-0031-1281676. Cited in this article [1]

[21]	Li T, Li J, Hu Z, et al. An ultrasound based method for predicting the malignant potential of primary gastrointestinal stromal tumors preoperatively[J]. Abdom Radiol (NY), 2024, 49(12):4189-4197.DOI:10.1007/s00261-024-04341-5. Cited in this article [1]

[22]	He P, Zeng L, Miao L, et al. Double contrast-enhanced ultrasound for the preoperative gross classification of gastric cancer:a comparison with multidetector computed tomography[J]. BMC Med Imaging, 2022, 22(1):223.DOI:10.1186/s12880-022-00954-8. Cited in this article [2]

[23]	He P, Miao LY, Ge HY, et al. Preoperative tumor staging of gastric cancer:comparison of double contrast-enhanced ultrasound and multidetector computed tomography[J]. J Ultrasound Med, 2019, 38(12):3203-3209.DOI:10.1002/jum.15028. Cited in this article [2]

[24]	Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China,2022[J]. J Natl Cancer Cen, 2024, 4(1):47-53.DOI:10.1016/j.jncc.2024.01.006. Cited in this article [1]

[25]	Sui A, Hu Z, Xie X, et al. Automatic detection of gastric wall structure based on oral contrast-enhanced ultrasound and its application on tumor screening[J]. Front Oncol, 2021, 11:627556.DOI:10.3389/fonc.2021.627556. Cited in this article [1]

[26]	Zhou SF, Yin JB, Yang H, et al. Application value of stomach filling ultrasonography and intravenous contrast agents in diagnosis of advanced gastric cancer[J]. Eur Rev Med Pharmacol Sci, 2016, 20(15):3206-3210. Cited in this article [1]

[27]	Li T, Lu M, Song J, et al. Improvement to ultrasonographical differential diagnosis of gastric lesions:the value of contrast enhanced sonography with gastric distention[J]. PLoS One, 2017, 12(8):e0182332.DOI:10.1371/journal.pone.0182332. Cited in this article [1]

[28]	Shiyan L, Pintong H, Zongmin W, et al. The relationship between enhanced intensity and microvessel density of gastric carcinoma using double contrast- enhanced ultrasonography[J]. Ultrasound Med Biol, 2009, 35(7):1086-1091.DOI:10.1016/j.ultrasmedbio.2009.03.010. Cited in this article [2]

[29]

Neciu C, Badea R, Chiorean L, et al. Oral and I.V.contrast enhanced ultrasonography of the digestive tract-a useful completion of the B-mode examination:a literature review and an exhaustive illustration through images[J]. Med Ultrason, 2015, 17(1):62-73.DOI:10.11152/mu.2013.2066.171.cnrb. Cited in this article [1]

[30]

He X, Sun J, Huang X, et al. Comparison of oral contrast-enhanced transabdominal ultrasound imaging with transverse contrast-enhanced computed tomography in preoperative tumor staging of advanced gastric carcinoma[J]. J Ultrasound Med, 2017, 36(12):2485-2493.DOI:10.1002/jum.14290. Cited in this article [2]

[31]	Wang CY, Fan XJ, Wang FL, et al. Clinical value of oral contrast-enhanced ultrasonography in diagnosis of gastric tumors[J]. World J Gastrointest Oncol, 2024, 16(1):110-117.DOI:10.4251/wjgo.v16.i1.110. Cited in this article [2]

[32]

Wu LL, Xin JY, Wang JJ, et al. Prospective comparison of oral contrast-enhanced transabdominal ultrasound imaging with contrast-enhanced computed tomography in pre-operative tumor staging of gastric cancer[J]. Ultrasound Med Biol, 2023, 49(2):569-577.DOI:10.1016/j.ultrasmedbio.2022.10.010. Cited in this article [2]

[33]

You MW, Park S, Kang HJ, et al. Radiologic serosal invasion sign as a new criterion of T4a gastric cancer on computed tomography:diagnostic performance and prognostic significance in patients with advanced gastric cancer[J]. Abdom Radiol (NY), 2020, 45(10):2950-2959.DOI:10.1007/s00261-019-02156-3. Cited in this article [1]

[34]	Lee KG, Shin CI, Kim SG, et al. Can endoscopic ultrasonography (EUS) improve the accuracy of clinical T staging by computed tomography (CT) for gastric cancer[J]. Eur J Surg Oncol, 2021, 47(8):1969-1975.DOI:10.1016/j.ejso.2021.02.031. Cited in this article [2]

[35]	Yu T, Wang X, Zhao Z, et al. Prediction of T stage in gastric carcinoma by enhanced CT and oral contrast-enhanced ultrasonography[J]. World J Surg Oncol, 2015,13:184. DOI:10.1186/s12957-015-0577-7. Cited in this article [1]

[36]	Xu YF, Ma HY, Huang GL, et al. Double contrast-enhanced ultrasonography improves diagnostic accuracy of T staging compared with multi-detector computed tomography in gastric cancer patients[J]. World J Gastroenterol, 2024, 30(23):3005-3015.DOI:10.3748/wjg.v30.i23.3005. Cited in this article [3]

[37]	Moshe DL, Baghaie L, Leroy F, et al. Metamorphic effect of angiogenic switch in tumor development:conundrum of tumor angiogenesis toward progression and metastatic potential[J]. Biomedicines, 2023, 11(8):2142.DOI:10.3390/biomedicines11082142. Cited in this article [1]

[38]	Mahase E. Cancer:GPs can order CT,ultrasound,and MRI scans for vague symptoms[J]. BMJ, 2022, 379:o2760.DOI:10.1136/bmj.o2760. Cited in this article [1]

[39]	Zhang G, Ye HR, Sun Y, et al. Ultrasound molecular imaging and its applications in cancer diagnosis and therapy[J]. ACS Sens, 2022, 7(10):2857-2864.DOI:10.1021/acssensors.2c01468. Cited in this article [1]

[40]	Li S, Huang P, Wang Z, et al. Preoperative T staging of advanced gastric cancer using double contrast-enhanced ultrasound[J]. Ultraschall Med, 2012, 33(7):E218-E224.DOI:10.1055/s-0032-1312958. Cited in this article [1]

[41]	陈瑞杰, 黄品同, 李艳萍, 等. 胃窗超声造影与超声双重造影对进展期胃癌术前T分期的比较[J]. 中华肿瘤杂志, 2010, 32(7):551-554.DOI:10.3760/cma.j.issn.0253-3766.2010.07.019. Cited in this article [1]

[42]	王成龙, 杨勇明, 崔健, 等. 双重超声造影在胃癌术前分期中的价值[J]. 中华肿瘤杂志, 2009, 31(9):701-704. DOI:10.3760/cma.j.issn.0253-3766.2009.09.014. Cited in this article [1]

[43]	Wang N, Yan X, Zhang Z, et al. Whether the use of intravenous contrast-enhanced ultrasound can improve the accuracy of T stage diagnosis of gastric cancer[J]. Clin Hemorheol Microcirc, 2024, 86(4):433-440.DOI:10.3233/CH-231949. Cited in this article [1]

[44]	Hu C, Feng Y, Huang P, et al. Adverse reactions after the use of SonoVue contrast agent:characteristics and nursing care experience[J]. Medicine, 2019, 98(44):e17745.DOI:10.1097/md.0000000000017745. Cited in this article [1]

[45]	Coudray S, Fabre C, Aichoun I, et al. Anaphylactic shock with an ultrasound contrast agent[J]. J Med Vasc, 2017, 42(6):384-387.DOI:10.1016/j.jdmv.2017.10.001. Cited in this article [1]

[46]	Zheng Z, Yu Y, Lu M, et al. Double contrast-enhanced ultrasonography for the preoperative evaluation of gastric cancer:a comparison to endoscopic ultrasonography with respect to histopathology[J]. Am J Surg, 2011, 202(5):605-611. DOI:10.1016/j.amjsurg.2010.09.033. Cited in this article [2]

[47]	Xu Q, Sun Z, Li X, et al. Advanced gastric cancer:CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy[J]. Eur Radiol, 2021, 31(11):8765-8774.DOI:10.1007/s00330-021-07962-2. Cited in this article [1]

[48]	Nie T, Liu D, Ai S, et al. A radiomics nomogram analysis based on CT images and clinical features for preoperative Lauren classification in gastric cancer[J]. Jpn J Radiol, 2023, 41(4):401-408.DOI:10.1007/s11604-022-01360-4. Cited in this article [1]

[49]	Liu DY, Hu JJ, Zhou YQ, et al. Analysis of lymph node metastasis and survival prognosis in early gastric cancer patients:a retrospective study[J]. World J Gastrointest Surg, 2024, 16(6):1637-1646.DOI:10.4240/wjgs.v16.i6.1637. Cited in this article [1]

[50]

Ri M, Yamashita H, Gonoi W, et al. Identifying multiple swollen lymph nodes on preoperative computed tomography is associated with poor prognosis along with pathological extensive nodal metastasis in locally advanced gastric cancer[J]. Eur J Surg Oncol, 2022, 48(2):377-382.DOI:10.1016/j.ejso.2021.08.017. Cited in this article [1]

[51]	Liu Y, Liu G, Hou B, et al. Ultrasound intervention combined with multi-slice spiral CT has excellent diagnostic value in lymph node metastasis of gastric cancer[J]. Am J Transl Res, 2021, 13(10):11764-11770. Cited in this article [1]

[52]	Guo Z, Jing X, Sun X, et al. Tumor angiogenesis and anti-angiogenic therapy[J]. Chin Med J (Engl), 2024, 137(17):2043-2051.DOI:10.1097/cm9.0000000000003231. Cited in this article [1]

[53]	Lidonnici J, Oberkersch RE. Reciprocal dynamics of metabolism and mRNA translation in tumor angiogenesis[J]. Int J Mol Sci, 2024, 25(20):11284.DOI:10.3390/ijms252011284. Cited in this article [1]

[54]	Faria PCL, Resende RS, Cardoso AM. Metastasis and angiogenesis in cervical cancer:key aspects of purinergic signaling in platelets and possible therapeutic targets[J]. Purinergic Signal, 2024, 20(6):607-616.DOI:10.1007/s11302-024-10020-3. Cited in this article [1]

[55]	Lorenc P, Sikorska A, Molenda S, et al. Physiological and tumor-associated angiogenesis:Key factors and therapy targeting VEGF/VEGFR pathway[J]. Biomed Pharmacother, 2024, 180:117585.DOI:10.1016/j.biopha.2024.117585. Cited in this article [1]

[56]	Korbecki J, Bosiacki M, Barczak K, et al. The clinical significance and role of CXCL1 chemokine in gastrointestinal cancers[J]. Cells, 2023, 12(10):1406.DOI:10.3390/cells12101406. Cited in this article [1]

[57]	Qiu Y, Lu G, Li N, et al. Exosome-mediated communication between gastric cancer cells and macrophages:implications for tumor microenvironment[J]. Front Immunol, 2024, 15:1327281.DOI:10.3389/fimmu.2024.1327281. Cited in this article [1]

[58]	Xue N, Huang P, Aronow WS, et al. Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography[J]. Arch Med Sci, 2011, 7(3):457-464.DOI:10.5114/aoms.2011.23412. Cited in this article [1]

[59]	Li SY, Huang PT, Xu HS, et al. Enhanced intensity on preoperative double contrast-enhanced sonography as a useful indicator of lymph node metastasis in patients with gastric cancer[J]. J Ultrasound Med, 2014, 33(10):1773-1781.DOI:10.7863/ultra.33.10.1773. Cited in this article [1]

[60]	Borrmann R. Makroskopishe formen des vorgeschritteten magenkrebse[M]//Henke F,Lubarsch D,Eds.Handbuch der speziellen anatomie und histologie,vol4/1.Berlin:Springer, 1926. Cited in this article [1]

[61]	Akimoto E, Kinoshita T, Yura M, et al. Feasibility of laparoscopic/robot- assisted surgery for Borrmann type 4 gastric cancer:a comparison study with conventional open surgery[J]. Surg Endosc, 2024, 38(6):3337-3345.DOI:10.1007/s00464-024-10857-0. Cited in this article [1]

[62]	Diaz Del Arco C, Ortega Medina L, Estrada Munoz L, et al. Are Borrmann’s types of advanced gastric cancer distinct clinicopathological and molecular Entities? A Western study[J]. Cancers (Basel), 2021, 13(12):3081.DOI:10.3390/cancers13123081. Cited in this article [1]

[63]	Oh MJ, Park J, Jeon J, et al. Application of artificial intelligence in the detection of Borrmann type 4 advanced gastric cancer in upper endoscopy (with video)[J]. Cancer, 2025, 131(4):e35768.DOI:10.1002/cncr.35768. Cited in this article [1]

[64]	Song XH, Zhang WH, Kai L, et al. Prognostic impact of Borrmann classification on advanced gastric cancer:a retrospective cohort from a single institution in Western China[J]. World J Surg Oncol, 2020, 18(1):204.DOI:10.1186/s12957-020-01987-5. Cited in this article [1]

[65]	Wang H, Yin X, Ma K, et al. Nomogram based on preoperative fibrinogen and systemic immune-inflammation index predicting recurrence and prognosis of patients with Borrmann type Ⅲ advanced gastric cancer[J]. J Inflamm Res, 2023, 16:1059-1075.DOI:10.2147/JIR.S404585. Cited in this article [1]

[66]	Pan M, Huang P, Li S, et al. Double contrast-enhanced ultrasonography in preoperative Borrmann classification of advanced gastric carcinoma:comparison with histopathology[J]. Sci Rep, 2013,3:3338.DOI:10.1038/srep03338. Cited in this article [2]

[67]	Wang L, Wang X, Kou H, et al. Comparing single oral contrast-enhanced ultrasonography and double contrast-enhanced ultrasonography in the preoperative Borrmann classification of advanced gastric cancer[J]. Oncotarget, 2018, 9(9):8716-8724.DOI:10.18632/oncotarget.23819. Cited in this article [1]

[68]	Yan C, Bao X, Shentu W, et al. Preoperative gross classification of gastric adenocarcinoma:comparison of double contrast-enhanced ultrasound and multi-detector row CT[J]. Ultrasound Med Biol, 2016, 42(7):1431-1440.DOI:10.1016/j.ultrasmedbio.2016.01.030. Cited in this article [1]

[69]	Oue N, Sentani K, Sakamoto N, et al. Molecular carcinogenesis of gastric cancer:Lauren classification,mucin phenotype expression,and cancer stem cells[J]. Int J Clin Oncol, 2019, 24(7):771-778.DOI:10.1007/s10147-019-01443-9. Cited in this article [1]

[70]

Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, et al. Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification,inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis[J]. Histol Histopathol, 2021, 36(6):587-613.DOI:10.14670/hh-18-309. Cited in this article [1]

[71]	Mariette C, Carneiro F, Grabsch HI, et al. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma[J]. Gastric Cancer, 2019, 22(1):1-9.DOI:10.1007/s10120-018-0868-0. Cited in this article [1]

[72]	Huang P, Li S, Aronow WS, et al. Double contrast-enhanced ultrasonography evaluation of preoperative Lauren classification of advanced gastric carcinoma[J]. Arch Med Sci, 2011, 7(2):287-293.DOI:10.5114/aoms.2011.22080. Cited in this article [1]

[73]	Wei F, Huang P, Li S, et al. Enhancement patterns of gastric carcinoma on contrast-enhanced ultrasonography:relationship with clinicopathological features[J]. PLoS One, 2013, 8(9):e73050.DOI:10.1371/journal.pone.0073050. Cited in this article [2]

[74]

Wang Y, Li L, Wang YX, et al. Time-intensity curve parameters in rectal cancer measured using endorectal ultrasonography with sterile coupling gels filling the rectum:correlations with tumor angiogenesis and clinicopathological features[J]. Biomed Res Int, 2014,2014:587806.DOI:10.1155/2014/587806. Cited in this article [1]

[75]	Stock K, Hann von Weyhern C, Slotta-Huspenina J, et al. Microcirculation of subepithelial gastric tumors using contrast-enhanced ultrasound[J]. Clin Hemorheol Microcirc, 2010, 45(2-4):225-232.DOI:10.3233/ch-2010-1302. Cited in this article [1]

[76]	Kuroki K, Oka S, Tanaka S, et al. Clinical significance of endoscopic ultrasonography in diagnosing invasion depth of early gastric cancer prior to endoscopic submucosal dissection[J]. Gastric Cancer, 2021, 24(1):145-155.DOI:10.1007/s10120-020-01100-5. Cited in this article [1]

[77]	Yeh JH, Yeh YS, Tsai HL, et al. Neoadjuvant chemoradiotherapy for locally advanced gastric cancer:Where are we at[J]. Cancers (Basel), 2022, 14(12):3026.DOI:10.3390/cancers14123026. Cited in this article [1]

[78]	Kim HD, Ryu MH, Kang YK. Adjuvant treatment for locally advanced gastric cancer:an Asian perspective[J]. Gastric Cancer, 2024, 27(3):439-450.DOI:10.1007/s10120-024-01484-8. Cited in this article [1]

[79]	Gervaso L, Ciardiello D, Oliveira RA, et al. Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors:is the time ripe[J]. J Immunother Cancer, 2024, 12(5):e008027. DOI:10.1136/jitc-2023-008027. Cited in this article [1]

[80]

Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada[J]. J Natl Cancer Inst, 2000, 92(3):205-216.DOI:10.1093/jnci/92.3.205. Cited in this article [1]

[81]	Ang J, Hu L, Huang PT, et al. Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy[J]. World J Gastroenterol, 2012, 18(47):7026-7032.DOI:10.3748/wjg.v18.i47.7026. Cited in this article [1]

[82]	鄢曹鑫, 黄品同, 申屠伟慧, 等. 双重造影增强超声QontraXt三维伪彩色定量分析评价进展期胃癌新辅助化疗疗效的价值[J]. 中华肿瘤杂志, 2018, 40(11):857-863.DOI:10.3760/cma.j.issn.0253-3766.2018.11.012. Cited in this article [1]